Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance)
Inhibit sodium-glucose cotransporter 2, decreasing glucose reabsorption in the proximal tubule
Potential serious adverse event: euglycemic DKA
Diabetes medications
CHF medications
Diabetes mellitus 
Tono-Pen use
Hypertension 
Drugs of abuse
Intravenous drug use
Metformin